Pfizer Inc. (NYSE: PFE) Q2 2020 earnings call dated July 28, 2020 https://youtu.be/aJVrijDiyOk Corporate Participants: Chuck Triano -- Senior Vice President, Investor Relations Albert
Pfizer Inc. (PFE) Q2 2020 Earnings Call Transcript
Pfizer Inc. (NYSE: PFE) Q2 2020 earnings call dated July 28, 2020 https://youtu.be/aJVrijDiyOk Corporate Participants: Chuck Triano -- Senior Vice President, Investor Relations Albert
Shares of Pfizer Inc. (NYSE: PFE) were up more than 4% on Tuesday after the company beat revenue and earnings estimates for
Pfizer Inc. (NYSE:PFE) reported second quarter 2020 earnings results today. Revenues fell 11% to $11.8 billion. The decline was 9% on an
Trxade Group Inc. (NASDAQ: MEDS) Q2 2020 earnings call dated July 27, 2020 Corporate Participants: Suren Ajjarapu -- Founder, Chairman and Chief Executive Officer
Quest Diagnostics Inc (NYSE: DGX) Q2 2020 earnings call dated July 23, 2020 Corporate Participants: Shawn Bevec -- Vice President, Investor Relations Stephen H.
Quest Diagnostics (NYSE: DGX) reported second-quarter financial results before the regular market hours on Thursday. The Q2 earnings were a cent higher
Align Technology Inc. (NASDAQ: ALGN) Q2 2020 earnings call dated July 22, 2020 Corporate Participants: Shirley Stacy -- Vice President, Corporate and Investor Communications
IQVIA Holdings Inc. (NYSE: IQV) Q2 2020 earnings call dated July 22, 2020 Corporate Participants: Andrew Markwick -- Senior Vice President, Investor Relations and
Thermo Fisher Scientific Inc. (NYSE: TMO) Q2 2020 earnings call dated Jul. 22, 2020 Corporate Participants: Kenneth Apicerno -- Vice President, Investor Relations Marc
Biogen Inc. (NASDAQ: BIIB) Q2 2020 earnings call dated July 22, 2020 Corporate Participants: Joe Mara -- Vice President of Finance and Head of
Novartis International AG (NYSE: NVS) Q2 2020 earnings call dated Jul. 21, 2020 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vasant
Biogen (NASDAQ: BIIB) reported a 12% increase in adjusted EPS and 2% growth in revenue for the second quarter of 2020. Adjusted
Thermo Fisher Scientific Inc. (NYSE: TMO) today announced its second quarter financial results for the period ended June 27, 2020. Net income
Intuitive Surgical, Inc. (NASDAQ: ISRG) reported second quarter 2020 earnings results today. Revenues decreased 22% year-over-year to $852 million, due to lower
Thanks to the COVID-19 testing growth, after reporting solid second quarter results and strong outlook for fiscal 2020 last Thursday, shares of
AngioDynamics, Inc. (NASDAQ: ANGO) Q4 2020 earnings call dated July 16, 2020 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Abbott Laboratories (NYSE: ABT) Q2 2020 earnings call dated July 16, 2020 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions
Johnson & Johnson (NYSE: JNJ) Q2 2020 earnings call dated July 16, 2020 Corporate Participants: Chris DelOrefice -- Vice President, Investor Relations Paul Stoffels -- Vice
Johnson & Johnson (NYSE: JNJ) saw revenue and earnings decline for the second quarter of 2020 but both the top and bottom
Abbott Laboratories (NYSE: ABT) reported second-quarter financial results before the regular trading hours on Thursday. Revenue for the quarter fell 8% to
AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020. Net loss for the